SOPH
SOPHiA GENETICS SA
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$6.49
−3.57%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.65x
- Price / sales
- 6.41x
- Price / cash flow
- -13.28x
Enterprise value
- Enterprise value
- $506.6M
- EV / sales
- 5.88x
- EV / EBITDA
- -7.94x
- EV / EBIT
- -6.92x
- Market cap
- $552.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026